AliperTherapeutics

Switzerland
Bellinzona, Ticino, Switzerland, 6500

Company profile

AliperTherapeutics company profile

AliperTherapeutics offers pharmacological treatments for prostate cancer using a bacteria-based medication. Its technology promises to improve the efficacy of existing medicines and delay the onset of severe types of the disease. The headquarters of the corporation are in Bellinzona, Switzerland.

Business identity

Operating status
Active
Company type
For Profit

Headquarters

Postal code
6500
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Non Equity Assistance / 2022-12-02
Investors
1
Lead investors
1

Categories and groups

Founders and investors

Lead investors

Boldbrain Startup Challenge

Investors

Boldbrain Startup Challenge